93 related articles for article (PubMed ID: 7708327)
1. Clocking the progress of Alzheimer's.
Gray-Vickrey P
Nursing; 1995 Apr; 25(4):32CCC-32HHH. PubMed ID: 7708327
[No Abstract] [Full Text] [Related]
2. Alzheimer's disease.
Kennedy-Malone LM; Fletcher K
Lippincotts Prim Care Pract; 1999; 3(2):163-8. PubMed ID: 10426059
[No Abstract] [Full Text] [Related]
3. Alzheimer's disease: how research is changing primary care management. Interview by Marc E. Weksler.
marotta C
Geriatrics; 1994 Jul; 49(7):47-51. PubMed ID: 8020762
[No Abstract] [Full Text] [Related]
4. Management of Alzheimer's disease.
Cohen GD
Adv Intern Med; 1995; 40():31-67. PubMed ID: 7747651
[No Abstract] [Full Text] [Related]
5. Advances in diagnosing and treating Alzheimer's disease.
Johns Hopkins Med Lett Health After 50; 1998 Sep; 10(7):4-6. PubMed ID: 9715123
[No Abstract] [Full Text] [Related]
6. Alzheimer's disease: a new hope.
Hasan MK; Mooney D
W V Med J; 1994 Oct; 90(10):418-9. PubMed ID: 7801627
[TBL] [Abstract][Full Text] [Related]
7. Tacrine therapy for the dementia of Alzheimer's disease.
Manning FC
Am Fam Physician; 1994 Sep; 50(4):819-26. PubMed ID: 8079912
[TBL] [Abstract][Full Text] [Related]
8. Maximizing function in Alzheimer's disease: what role for tacrine?
Smucker WD
Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: are we making any progress?
Edwards KS
Ohio Med; 1989 Nov; 85(11):864-9, 872, 886. PubMed ID: 2601934
[No Abstract] [Full Text] [Related]
10. [Treatments of Alzheimer's disease].
Vidal C; Sastre N; Ousset PJ
Soins Gerontol; 1999; (16):7-8. PubMed ID: 10745912
[No Abstract] [Full Text] [Related]
11. New Alzheimer's drug expands your options in symptom management.
Wolf-Klein GP
Geriatrics; 1993 Aug; 48(8):26-9, 33-6. PubMed ID: 8339940
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease.
Butler RN
Geriatrics; 1998 Apr; 53(4):3-4. PubMed ID: 9559023
[No Abstract] [Full Text] [Related]
13. Tacrine and lecithin in Alzheimer's disease. Tacrine is safe and effective.
Pendlebury WW; Solomon PR
BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019290
[No Abstract] [Full Text] [Related]
14. [Tetrahydroaminoacridine or THA. Disputed value in Alzheimer's type dementia].
Chatellier G
Rev Prat; 1993 Mar; 43(6):725-8. PubMed ID: 8341950
[No Abstract] [Full Text] [Related]
15. Alzheimer's disease management.
Cummings JL
J Clin Psychiatry; 1998; 59 Suppl 13():4-5. PubMed ID: 9771824
[No Abstract] [Full Text] [Related]
16. [Alzheimer's disease].
Palo J
Duodecim; 1985; 101(19):1847-51. PubMed ID: 4064962
[No Abstract] [Full Text] [Related]
17. Reports from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). The efficacy of Tacrine and the measurement of outcomes of Alzheimer's disease.
Int J Technol Assess Health Care; 1998; 14(2):398-9. PubMed ID: 9678977
[No Abstract] [Full Text] [Related]
18. [Tacrine in Alzheimer's disease].
López de Munain A
Rev Neurol; 1997 Jul; 25 Suppl 1():S70-2. PubMed ID: 9280671
[No Abstract] [Full Text] [Related]
19. [Alzheimer's disease and general medicine: what are the conditions for the early diagnosis and efficient treatment?].
Gallais JL; Pouchain D
Encephale; 2000 Apr; 26 Spec No 3():36-45. PubMed ID: 10858931
[No Abstract] [Full Text] [Related]
20. Tacrine in Alzheimer's disease.
Lachs M
N Engl J Med; 1993 Mar; 328(11):809-10. PubMed ID: 8437606
[No Abstract] [Full Text] [Related]
[Next] [New Search]
